Can You Switch from In-Person to Telehealth for GLP-1s? Here's How

Maybe your doctor retired. Maybe your insurance stopped covering brand-name GLP-1s. Maybe you moved to a new state and can't find a prescriber taking new patients. Whatever the reason, switching from an in-person provider to a telehealth platform for your GLP-1 medication is increasingly common — and it's simpler than most patients expect.

When Switching Makes Sense

Insurance coverage changes. If your insurer drops GLP-1 coverage, the retail price of brand-name Wegovy ($1,300+/month) or Zepbound ($1,000+/month) makes telehealth compounded alternatives at $130–200/month compelling even if you preferred the brand-name product.

Provider availability. Endocrinologists and obesity medicine specialists have long wait lists. If your current provider leaves the practice or isn't available for timely follow-ups, a telehealth platform can provide continuity without a gap in treatment.

Geographic relocation. Moving to a new state means finding a new provider licensed in that state. Telehealth platforms with multi-state prescriber networks can bridge this gap immediately.

Cost reduction. Even with insurance, GLP-1 copays can be substantial. If you've been stable on your medication for months, switching to a compounded version through telehealth can save hundreds per month with the same active ingredient at the same dose.

What You'll Need

Current medication details. Know your exact medication (semaglutide or tirzepatide), current dose, how long you've been on it, and your titration history. Your telehealth prescriber needs this to continue your treatment without an unnecessary restart from the lowest dose.

Recent lab work. Bring the most recent lab results your previous provider ordered — metabolic panel, thyroid function, kidney function, A1C if applicable. If your labs are older than 6–12 months, the telehealth platform may order new ones.

Medical records summary. You don't need your entire chart, but a summary of your weight management history, any GLP-1 side effects you've experienced, dose adjustments, and comorbidities will help your new prescriber get up to speed.

Timing. Start the telehealth enrollment process before your current supply runs out. A 2–3 week overlap gives enough time for intake, consultation, pharmacy processing, and shipping without a gap in treatment. Interrupting GLP-1 therapy and restarting later can require re-titrating from a lower dose.

The Switching Process

Step 1: Enroll with the telehealth platform. Complete the intake form, noting that you're an existing GLP-1 patient switching providers. Specify your current medication and dose. Upload recent lab work if you have it.

Step 2: Consultation. Your telehealth prescriber will review your history. Because you're already on GLP-1 medication, the consultation focuses on confirming your current dose is appropriate, checking for any new contraindications, and establishing a follow-up schedule. This is typically faster than a new-patient consultation.

Step 3: Prescription and delivery. Your prescriber writes the prescription at your current dose — no re-titration required if you've been stable. The pharmacy compounds and ships your medication, typically within 5–7 business days.

Step 4: Notify your previous provider. As a courtesy and for medical record continuity, inform your previous prescriber that you've transferred GLP-1 management to a telehealth provider. If you're keeping your PCP for other care, make sure they know about the switch so they can coordinate appropriately.

Brand-Name to Compounded: What Changes

If you're switching from brand-name (Wegovy, Ozempic, Zepbound) to compounded medication, the active ingredient is the same but the delivery device and formulation differ. Brand-name medications come in pre-filled pens with fixed doses. Compounded medications typically come in multi-dose vials that require drawing up the correct dose with a syringe.

This means learning a new injection technique — drawing from a vial rather than clicking a pen. Most telehealth platforms provide instruction videos and written guides. The injection itself is the same (subcutaneous, typically in the abdomen or thigh), but the preparation step is different.

The dose may also need slight adjustment. Brand-name semaglutide uses a specific salt form (semaglutide sodium), while compounded versions may use the base form. Your prescriber should account for this in dosing calculations — if they don't mention it, ask.

Platforms Built for Transitions